Basic characteristics of healthy subjects and patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)
| Women | Men | p Value | |
|---|---|---|---|
| Data are given as means (SEM). | |||
| ASD, androstenedione. | |||
| The values are not given for comparison of subgroups because body mass index was not available. For this particular leptin assay, the supplier provided mean values for women and men of 20 676 pg/ml (range 3877–77 273) and 4760 pg/ml (2205–11 149), respectively (R&D Systems, Wiesbaden, Germany). | |||
| Healthy subjects | |||
| Serum leptin (pg/ml) | 14490 (2946) | 4715 (610) | <0.001 |
| Serum ASD (nmol/l) | 13.5 (1.3) | 15.6 (1.6) | NS |
| Systemic lupus erythematosus | |||
| Serum leptin (pg/ml) | 11999 (1643) | 6319 (2167) | 0.064 |
| Serum ASD (nmol/l) | 4.6 (0.9) | 6.7 (2.0) | NS |
| Rheumatoid arthritis | |||
| Serum leptin (pg/ml) | 3973 (572) | 2186 (554) | 0.047 |
| Serum ASD (nmol/l) | 1.9 (0.3) | 3.0 (0.6) | NS |